Cancer Milestones
The ancient physician Hippocrates described the projection of blood vessels from a collection of cells as ‘karkinos’, the Greek word for crab. Today, we know this malignant growth as cancer. Although it remains one of our biggest killers, survival rates for several tumour types have improved dramatically in recent years. These Milestones celebrate two decades of breakthroughs in basic, translational and clinical research which have revolutionised our understanding and management of cancer.
This Milestone is editorially independent, produced with financial support from a third party. About this content.
Co-ordinating editors:
Safia Danovi, Nature Genetics
Saheli Sadanand, Nature Medicine
Writing and handling editors:
Javier Carmona, Nature Medicine
Megan Cully, Nature Reviews Drug Discovery
Anna Dart, Nature Reviews Cancer
Iain Dickson, Nature Reviews Gastroenterology & Hepatology
Michael Fletcher, Nature Genetics
Miguel Foronda, Nature Cancer
Linda Gummlich, BMC Cancer
Ulrike Harjes, Nature Reviews Cancer
David Killock, Nature Reviews Clinical Oncology
Linda Koch, Nature Reviews Genetics
Barbara Marte, Nature
Diana Romero, Nature Reviews Clinical Oncology
Sarah Seton-Rogers, Nature Reviews Cancer
Peter Sidaway, Nature Reviews Clinical Oncology
Ilse Valtierra, Nature Communications
M. Teresa Villanueva, Nature Reviews Drug Discovery
Monica Wang, Nature Reviews Nephrology
Advisors:
David J. Adams, Wellcome Trust Sanger Institute, United Kingdom
Catherine Alix-Panabières, University of Montpellier, France
René Bernards, Netherlands Cancer Institute, the Netherlands
Trever G. Bivona, University of California, San Francisco, USA
Navdeep S. Chandel, Northwestern University, USA
Ryan B. Corcoran, Dana-Farber Cancer Institute, USA
Sarah-Jane Dawson, Peter MacCallum Cancer Centre, Australia
Julian Downward, The Francis Crick Institute, United Kingdom
Kristian Helin, Memorial Sloan Kettering Cancer Center, USA
Jakob N. Kather, University Hospital RWTH Aachen and German Cancer Research Center, Germany
Christopher A. Klebanoff, Memorial Sloan Kettering Cancer Center, US
Crystal L. Mackall, Stanford University, USA
Ignacio Melero, CIMA and Clinica Universidad de Navarra, Spain
Narges Razavian, New York University, USA
John T. Schiller, National Institutes of Health, USA
Clemens A. Schmitt, Charité – University Medical Center and Max-Delbrück-Center for Molecular Medicine, Germany
Charles Swanton, The Francis Crick Institute and University College London Cancer Institute, United Kingdom
Giorgio Trinchieri, National Institutes of Health, USA
Laurence Zitvogel, Gustave Roussy Cancer Center, France
